ESR1 and breast cancer: Recent assessment of PD0332991 using short-term growth assays indicated that it was effective in inducing growth arrest of many estrogen receptor (ER) positive breast cancer cell lines, but that a number of ER(−) lines were able to maintain pRB phosphorylation and proliferation in its presence [200].